New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
10:40 EDTGRMNGarmin continues rally after another upbeat analyst note
Shares of Garmin (GRMN) are climbing after research firm Oppenheimer, in a note to investors earlier today, predicted that the shares could rise further. WHAT'S NEW: Noting that Garmin's stock has climbed recently, Oppenheimer analyst Yair Reiner wrote that the shares have more room to run. Specifically, the stock is likely to rise further this year as the company's new products gain momentum, he contended. Garmin's new fitness and aviation products are likely to do well, he predicted. Given the strength of these new offerings, analysts' estimates for Garmin are likely to increase, predicted Reiner, who views the stock's valuation as attractive. He kept a $65 price target and Outperform rating on the shares. WHAT'S NOTABLE: Citigroup yesterday upgraded its rating on Garmin to Buy from Neutral, citing what it sees as the positive outlook for the company's new fitness activity monitor, vivofit. PRICE ACTION: In mid-morning trading, Garmin surged 5% to $58.10. Earlier the company set a new 52-week high of $58.21.
News For GRMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
07:06 EDTGRMNGarmin to acquire DeLorme; financial terms not disclosed
Subscribe for More Information
February 10, 2016
06:59 EDTGRMNGarmin upgrades Volvo Penta glass cockpit system
Subscribe for More Information
06:56 EDTGRMNGarmin's Marine Electronics selected by Pursuit Boats
Subscribe for More Information
February 5, 2016
09:34 EDTGRMNGarmin estimates lowered at Cleveland Research
Cleveland Research lowered Garmin's 2016 revenue estimates to down 3% year-over-year, versus consensus of a decline of 1%, due to increased concerns regarding competition and a worsening outlook.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use